Latest News
Pelthos Therapeutics Inc.
- Pelthos Therapeutics Inc. (PTHS) - What Are Analysts Saying About This Stock?
- Pelthos Therapeutics (NYSEAMERICAN:PTHS) Stock Rating Lowered by Zacks Research
- Durham's Pelthos Therapeutics Expands Formulary Coverage for ZELSUVMI® to 127 Million Commercial Lives
- Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3%
- Pelthos Therapeutics director sells $11,560 in common stock
- Pelthos Therapeutics director Peter Greenleaf sells $16,872 in stock By Investing.com
- Pelthos expands ZELSUVMI coverage to 127 million lives
- Pelthos Therapeutics (NYSEAMERICAN:PTHS) Director Sells 558 Shares of Stock
- Pelthos Therapeutics (NYSEAMERICAN:PTHS) Stock: Insider Peter Greenleaf Sells 797 Shares
- Pelthos Therapeutics elects directors and approves new equity plan at annual meeting
Headlines from the last 30 days, linking to the original publishers. See all market news →